Effects of Dihydrotestosterone on Osteoblast Activity in Curdlan-Administered SKG Mice and Osteoprogenitor Cells in Patients with Ankylosing Spondylitis

    May 2020 in “ Arthritis research & therapy ”
    Sungsin Jo, Eun‐Ju Lee, Bora Nam, Jae Seon Kang, Seunghun Lee, Jeehee Youn, Ye‐Soo Park, Yong‐Gil Kim, So Yeon Kim
    New to Dutasteride? There is a guide in the encyclopedia. Read the guide →
    Studysummary This study found that dutasteride affected spinal bone formation in curdlan-treated SKG mice, while DHT treatment reduced osteoblast differentiation in vitro, suggesting that DHT inhibition might unexpectedly increase spinal ankylosis progression in ankylosing spondylitis patients. Our plain-language summary of this paper — not a Tressless recommendation.
    The study investigated the effects of dihydrotestosterone (DHT) and its inhibitor, dutasteride, on osteoblast activity in curdlan-administered SKG mice and osteoprogenitor cells from patients with ankylosing spondylitis (AS). Dutasteride treatment in mice increased spinal mineralization and IL-17A-secreting cells, suggesting exacerbation of AS pathology. In vitro, DHT delayed osteogenic differentiation by increasing DKK1 and SOST expression. Clinically, higher DHT levels in AS patients did not correlate with disease severity. The findings indicated that DHT inhibition might worsen spinal ankylosis in AS, warranting careful consideration of dutasteride use in these patients.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results